For the first time in 20 years, the United States FDA has approved a new drug for Alzheimer’s disease, news that brought both celebration and dismay. While patients and families suddenly glimpse hope, many researchers dismiss that hope as illusory.
NeuroCentrix provides access to clinical trials and potential new treatments for individuals with Alzheimer’s disease and Major Depression Disorder
Melbourne Head Office
1303 Heatherton Rd (enter via Beck Court), Noble Park VIC 3174